Vir Biotechnology, Inc. Business Operations Contracts & Agreements

23 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No.3 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2024
Amendment No. 2 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2024
Amendment No. 1 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2023
Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration for Strategic...
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
2023
Amendment No. 1 to the Definitive Collaboration Agreement between the Company and Glaxo Wellcome UK Limited dated May 27, 2022
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2022
Termination Agreement between the Company and WuXi Biologics (Hong Kong) Limited dated May 16, 2022
Termination Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2022
Preliminary Collaboration Agreement between the Company, GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Biologicals SA, dated February 14, 2021
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Development and Manufacturing Collaboration Agreement between the Company and Wuxi Biologics (Hong Kong) Limited, dated February 25, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
IL
2020
Clinical Development and Manufacturing Agreement between the Company and Biogen Inc., dated May 22, 2020
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Definitive Collaboration Agreement between the Company and Glaxo Wellcome UK Limited and Beecham S.A., dated June 9, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Preliminary Collaboration Agreement between the Company, GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Biologicals SA, dated April 5, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Amendment No. 3 to the Collaboration and License Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated April 1, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 2 to the Collaboration and License Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated March 3, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to the Collaboration and License Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 17, 2019
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Collaboration, Option, and License Agreement between the Registrant and Brii Biosciences Limited (previously named BiiG Therapeutics Limited), dated May 23, 2018
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Amendment 6 to Sub-License and Collaboration Agreement, dated September 7, 2018, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 5 to Sub-License and Collaboration Agreement, dated July 15, 2017, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated March...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 4 to Sub-License and Collaboration Agreement, dated August 29, 2016, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 3 to Sub-License and Collaboration Agreement, dated December 31, 2015, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 2 to Sub-License and Collaboration Agreement, dated April 27, 2015, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated March...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 1 to Sub-License and Collaboration Agreement, dated April 19, 2013, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated March...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Sub-License and Collaboration Agreement between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated March 20, 2012
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Collaboration and License Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated October 16, 2017
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
MA
2019